Early thrombocytopenia predicts longer time‑to‑treatment discontinuation in trastuzumab emtansine treatment.
Sahin AB, Caner B, Ocak B, Gulmez A, Hamitoglu B, Cubukcu E, Deligonul A, Orhan SO, Canhoroz M, Odman HU, Somali I, Ocakoglu G, Evrensel T.
Sahin AB, et al. Among authors: ocakoglu g.
Oncol Lett. 2023 Oct 23;26(6):523. doi: 10.3892/ol.2023.14110. eCollection 2023 Dec.
Oncol Lett. 2023.
PMID: 37927419
Free PMC article.